High Vista Strategies LLC Acadia Pharmaceuticals Inc Transaction History

High Vista Strategies LLC

$255 Million
Q3 2024

A detailed history of High Vista Strategies LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, High Vista Strategies LLC holds 25,287 shares of ACAD stock, worth $436,453. This represents 0.15% of its overall portfolio holdings.

Number of Shares

25,287

Previous 25,878 2.28%

Holding current value

$436,453

Previous $420,000 7.38%

% of portfolio

0.15%

Previous 0.17%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.14 - $19.14 $8,947 - $11,311	-591 Reduced 2.28%	25,287 $389,000
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $378,336 - $476,672	25,878 New	25,878 $420,000
Q3 2023 Nov 14, 2023	SELL	$20.84 - $33.47 $221,299 - $355,417	-10,619 Reduced 36.88%	18,172 $378,000
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $476,737 - $686,983	-26,783 Reduced 48.19%	28,791 $689,000
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $17,038 - $21,840	-1,044 Reduced 1.84%	55,574 $1.05 Million
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $46,860 - $61,479	3,300 Added 6.19%	56,618 $901,000
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $189,327 - $245,146	13,418 Added 33.63%	53,318 $872,000
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $75,249 - $157,440	5,784 Added 16.95%	39,900 $562,000
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $714,389 - $938,190	34,116 New	34,116 $826,000
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $321,846 - $454,897	-16,590 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $56,194 - $123,507	2,246 Added 15.66%	16,590 $428,000
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $78,591 - $108,752	1,915 Added 15.41%	14,344 $767,000
Q3 2020 Nov 16, 2020	BUY	$36.42 - $57.0 $132,386 - $207,195	3,635 Added 41.34%	12,429 $513,000
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $345,252 - $463,707	8,794 New	8,794 $426,000

Others Institutions Holding ACAD

# of Institutions

281

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.79B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Account

High Vista Strategies LLC Acadia Pharmaceuticals Inc Transaction History